FTV Capital Expands Internationally With Opening of London Office
As part of the expansion, Richard Earnshaw joins as partner to lead new office and FTV's European investing efforts alongside growing team FTV Capital, a prominent sector-focused growth equity investment firm with a
Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11
Morgan Stanley analyst Michael Infante maintains $Enfusion(ENFN.US)$ with a buy rating, and maintains the target price at $11.According to TipRanks data, the analyst has a success rate of 0.0% and a t
KKR to Acquire Majority Ownership in Agiloft
Existing investor FTV Capital to invest additional capital in the Company KKR, a leading global investment firm, today announced that a fund managed by KKR has entered into an agreement to acquire a majority stake in
Enfusion To Present at Upcoming Investor Events
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion's Chief Executive Officer, Oleg Movchan, and Chief
William Blair Maintains Enfusion(ENFN.US) With Buy Rating
William Blair analyst Dylan Becker maintains $Enfusion(ENFN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 65.6% and a total average return of 5.5% over the past
Buy Rating Affirmed for Enfusion on Strong Growth and Market Positioning Prospects
Insider Sale: Chief People Officer Bronwen Bastone Sells 34,059 Shares of Enfusion Inc (ENFN)
Enfusion(ENFN.US) Officer Sells US$325.26K in Common Stock
$Enfusion(ENFN.US)$ Officer Bastone Bronwen sold 34,059 shares of common stock on May 20, 2024 at an average price of $9.55 for a total value of $325.26K.Source: Announcement What is statement of chan
Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing
Bronwen Bastone, Chief People Officer, on May 20, 2024, sold 34,059 shares in Enfusion (ENFN) for $325,263. Following the Form 4 filing with the SEC, Bastone has control over a total of 227,693 shares
Form 144 | Enfusion(ENFN.US) Officer Proposes to Sell 325.4K in Common Stocks
SEC FILLINGS DISCLOSED/ May 20, $Enfusion(ENFN.US)$ Officer Bastone Bronwen intends to sell 34,059 shares of its common stock on May 20, with a total market value of approximately $325.4K. Source:
Enfusion Insiders Sell US$24m Of Stock, Possibly Signalling Caution
Many Enfusion, Inc. (NYSE:ENFN) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valua
Enfusion First Quarter 2024 Earnings: EPS Misses Expectations
Analysts Offer Insights on Technology Companies: Enfusion (ENFN), Vertex (VERX) and Shift4 Payments (FOUR)
Enfusion | 10-Q: Quarterly report
Enfusion Shares Fall Despite Higher Q1 Results
Enfusion (ENFN) shares fell 4.2% in recent Thursday trading after the company reported adjusted earnings of $0.06 per share, up from $0.03 a year earlier. Analysts surveyed by Capital IQ expected $0.0
Express News | Enfusion Inc Q1 Shr View $0.04 -- Lseg Ibes Data
Express News | Enfusion Inc - Qtrly Net Loss per Class a Common Shares Attributable to Co $0.01
Enfusion 1Q Rev $48.1M >ENFN
Enfusion 1Q Rev $48.1M >ENFN
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Estimate, Sales $48.052M Beat $47.616M Estimate
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 100 percent increase over earnings of $0.03 per share fr
Enfusion Announces First Quarter 2024 Results
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its first quarter 2024 financial results as part of its 1Q 2024
No Data